American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
DR
Drugs Made In America Acquisition II Corp.
$10.08
+0.00%
NASDAQ: DMII · 15-min delayed
$642.1MMarket cap
$4.2MNet income
2Employees
DMIINASDAQ
2025IPO
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp is a blank check Company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- $4.2M
- Total assets
- $505.0M
- Market cap
- $642.1M
Source: SEC EDGAR · updated Jun 8, 2026
FY 2025
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $488.4K
- Operating income
- -$488.4K
- Net income
- $4.2M
Balance sheet
- Total assets
- $505.0M
- Current assets
- $26.0K
- Total liabilities
- $17.8M
- Current liabilities
- $300.9K
Cash flow
- Operating cash flow
- -$1.0M
- Investing cash flow
- -$500.0M
- Financing cash flow
- $501.0M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
NASDAQ: DMII
$10.08
+0.00%
15-minute delayed · data by Polygon.io
Past year
$9.87
$10.08
52-week range
- Market cap
- $642.1M
- Shares outstanding
- 63.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 3, 2025
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $4.2M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Drugs Made In America Acquisition II Corp..
Write a review
Explore
Browse all →
